Amsurg Corp Com (AMSG) 72.23 $AMSG
Quest Diagnostics: Strong Q2, Strategic Initiatives Add Value
Zacks Equity Research - Zacks Investment Research - Mon Jul 25, 2:23PM CDT
On Jul 22, 2016, we issued an updated research report on Quest Diagnostics, Inc. (DGX).
AMSG: 72.23 (-2.78), HCA: 75.52 (-1.61), LHCG: 45.32 (+0.06), DGX: 86.24 (-0.12), BIOS: 2.58 (+0.02)
Will AmSurg's Merger with Envision Healthcare Drive Growth?
Zacks Equity Research - Zacks Investment Research - Fri Jul 15, 3:08PM CDT
AmSurg (AMSG) recently agreed to merge in an all-stock deal with Envision Healthcare to create one of the largest providers of physician services in the U.S.
AMSG: 72.23 (-2.78), BSX: 24.43 (+0.15), EVHC: 23.59 (-1.00), GWPH: 96.11 (+1.79), NUVA: 63.29 (+1.09)
Will Quest Diagnostics' (DGX) Earnings Surprise in Q2?
Zacks Equity Research - Zacks Investment Research - Thu Jul 14, 4:16PM CDT
Quest Diagnostics Inc. (DGX) is scheduled to report its first-quarter 2016 earnings results before the opening bell on Jul 21, 2016.
AMSG: 72.23 (-2.78), HCA: 75.52 (-1.61), DGX: 86.24 (-0.12), COO: 182.61 (+0.14)
Cross Keys Capital Completes Sale of AllegiantMD to Sheridan Healthcare
GlobeNewswire - Tue Jul 12, 10:16AM CDT
Cross Keys Capital, LLC, a leading independent investment banking firm providing M&A advisory services to healthcare companies, is pleased to announce that it has acted as the exclusive financial advisor to AllegiantMD, Inc. and certain affiliated entities in their sale to Sheridan Healthcare, the Physician Services Division of AmSurg Corporation. The transaction was led by Cross Keys' Managing Director Bill Britton and Vice President Marjorie Chang.
AMSG: 72.23 (-2.78)
Quest Diagnostics Estimates Move Up, Tie-Ups to Add Value
Zacks Equity Research - Zacks Investment Research - Tue Jul 12, 7:31AM CDT
On Jul 11, we issued an updated research report on Quest Diagnostics, Inc. (DGX).
AMSG: 72.23 (-2.78), HCA: 75.52 (-1.61), DGX: 86.24 (-0.12), BIOS: 2.58 (+0.02)
ENVISION HEALTHCARE HOLDINGS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to AMSURG Corp.
BusinessWire - Fri Jun 24, 1:17PM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Envision Healthcare Holdings, Inc. ("Envision"
(NYSE: EVHC) concerning the sale to AMSURG Corp. (NASDAQ: AMSG). Under the terms of the agreement, Envision shareholders will only receive 0.334 AMSURG shares for each share owned. The consideration is valued at approximately $26.21, which is significantly lower than the 52-week high and at least one analyst's estimated value of $36.00 per share.
AMSG: 72.23 (-2.78), EVHC: 23.59 (-1.00)
INVESTOR ALERT: Levi & Korsinsky, Notifies Envision Healthcare Holdings, Inc. Shareholders of an Investigation Regarding the Fairness of the Sale of the Company to AMSURG Corp. -- EVHC
PR Newswire - Thu Jun 23, 12:09PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
AMSG: 72.23 (-2.78), EVHC: 23.59 (-1.00)
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Envision Healthcare Holdings, Inc. - EVHC
ACCESSWIRE - Wed Jun 22, 8:35PM CDT
BALA CYNWYD, PA / ACCESSWIRE / June 22, 2016 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Envision Healthcare Holdings, Inc. ("Envision" or "the Company" (NYSE: EVHC) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to AmSurg Corp. ("AmSurg".
AMSG: 72.23 (-2.78), EVHC: 23.59 (-1.00)
SHAREHOLDER ALERT: Levi & Korsinsky, Notifies Shareholders of Envision Healthcare Holdings, Inc. of Commencement of an Investigation Regarding the Fairness of the Sale of the Company to AMSURG Corp. -- EVHC
ACCESSWIRE - Tue Jun 21, 5:16PM CDT
NEW YORK, NY / ACCESSWIRE / June 21, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:
AMSG: 72.23 (-2.78), EVHC: 23.59 (-1.00)
ENVISION HEALTHCARE SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Envision Healthcare Holdings, Inc. (EVHC) Over the Proposed Sale of the Company to AmSurg Corp.
PR Newswire - Tue Jun 21, 3:21PM CDT
Nadeem Faruqi, founding partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Envision Healthcare Holdings, Inc. ("Envision Healthcare" or the "Company" (NYSE:EVHC) for potential breaches of fiduciary duties in connection with the sale of the Company to AmSurg Corp. ("AmSurg" for approximately $4.73 billion.
AMSG: 72.23 (-2.78), EVHC: 23.59 (-1.00)
Envision Healthcare Holdings Inc. Acquisition May Not Be in the Best Interests of EVHC Shareholders
PR Newswire - Mon Jun 20, 10:30AM CDT
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Envision Healthcare Holdings Inc. ("EVHC" or the "Company" in connection with the Company's proposed plan of merger with AmSurg Corp. ("AmSurg", announced on June 15, 2016. Under the terms of the agreement, EVHC shareholders will receive 0.334 of a share of AmSurg common stock for each EVHC share they own, representing consideration of $25.89 per share.
AMSG: 72.23 (-2.78), EVHC: 23.59 (-1.00)
Ryan & Maniskas, LLP Announces Investigation of Envision Healthcare Holdings, Inc.
PR Newswire - Fri Jun 17, 9:45AM CDT
Ryan & Maniskas, LLP is investigating potential claims against the board of directors of Envision Healthcare Holdings, Inc. ("Envision" or the "Company" (NYSE: EVHC) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell the Company to AmSurg Corp. ("AmSurg" in a transaction valued at approximately $4.8 billion.
AMSG: 72.23 (-2.78), EVHC: 23.59 (-1.00)
AmSurg, Envision Healthcare Set to Merge by 2016-End
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 8:47AM CDT
Envision shareholders will own 53% of the combined entity while AmSurg (AMSG) shareholders will have 47%.
AMSG: 72.23 (-2.78), EVHC: 23.59 (-1.00), BAX: 48.50 (+0.48), LMAT: 17.89 (+0.69)
Upgrade Alert for Amsurg (AMSG)
Comtex SmarTrend(R) - Fri Jun 17, 3:38AM CDT
Amsurg (NASDAQ:AMSG) was upgraded from Neutral to Buy at BofA/Merrill today. The stock closed yesterday at $78.43 on volume of 3.0 million shares, above average daily volume of 523,000. There is potential upside of 17.0% for shares of Amsurg based on a current price of $78.43 and an average consensus analyst price target of $91.73. The stock should discover initial support at its 200-day moving average (MA) of $76.38 and subsequent support at its 50-day MA of $74.87.
AMSG: 72.23 (-2.78)
Robbins Arroyo LLP: Acquisition of Envision Healthcare Holdings, Inc. (EVHC) by AmSurg Corp. (AMSG) May Not Be in Shareholders' Best Interests
BusinessWire - Thu Jun 16, 1:14PM CDT
Shareholder rights attorneys at Robbins Arroyo LLP are investigating the proposed acquisition of Envision Healthcare Holdings, Inc. (NYSE: EVHC) by AmSurg Corp. (NASDAQ: AMSG). On June 15, 2016, the two companies announced the signing of a definitive merger agreement pursuant to which AmSurg will acquire Envision. Under the terms of the agreement, Envision shareholders will receive 0.334 shares of AmSurg common stock for each share of Envision common stock, the value of which is equivalent to $26.21.
AMSG: 72.23 (-2.78), EVHC: 23.59 (-1.00)
Amsurg Rises 2.23% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Thu Jun 16, 12:37PM CDT
Amsurg (NASDAQ:AMSG) traded in a range yesterday that spanned from a low of $78.00 to a high of $81.13. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $80.02 on volume of 2.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
AMSG: 72.23 (-2.78)
Envision Healthcare and AMSURG Announce Transformational Merger
BusinessWire - Wed Jun 15, 3:30PM CDT
Envision Healthcare Holdings, Inc. (Envision) (NYSE:EVHC) and AMSURG Corp. (AMSURG) (NASDAQ:AMSG) today announced that they have signed a definitive merger agreement pursuant to which the companies will combine in an all-stock transaction at a fixed exchange ratio of 0.334 AMSURG shares per Envision share. The combined organization will have a pro forma market capitalization of approximately $10 billion and enterprise value of approximately $15 billion based on the closing stock prices of Envision and AMSURG on June 14, 2016. Envision shareholders will own approximately 53% percent and AMSURG shareholders will own approximately 47% percent of the combined organization on a fully diluted basis, including preferred shares. The transaction has been unanimously approved by the Boards of Directors of both companies.
AMSG: 72.23 (-2.78), EVHC: 23.59 (-1.00)
Envision Healthcare (EVHC) in Focus: Stock Climbs 8.3% in Session
Zacks Equity Research - Zacks Investment Research - Fri Jun 10, 7:35AM CDT
Envision Healthcare Holdings, Inc. (EVHC) was a big mover last session, as the company saw its shares rise over 8% on the day.
AMSG: 72.23 (-2.78), EVHC: 23.59 (-1.00)
Quest Diagnostics: Strong Q2, Strategic Initiatives Add Value
Zacks Equity Research - Zacks Investment Research - Mon Jul 25, 2:23PM CDT
On Jul 22, 2016, we issued an updated research report on Quest Diagnostics, Inc. (DGX).
AMSG: 72.23 (-2.78), HCA: 75.52 (-1.61), LHCG: 45.32 (+0.06), DGX: 86.24 (-0.12), BIOS: 2.58 (+0.02)
Will AmSurg's Merger with Envision Healthcare Drive Growth?
Zacks Equity Research - Zacks Investment Research - Fri Jul 15, 3:08PM CDT
AmSurg (AMSG) recently agreed to merge in an all-stock deal with Envision Healthcare to create one of the largest providers of physician services in the U.S.
AMSG: 72.23 (-2.78), BSX: 24.43 (+0.15), EVHC: 23.59 (-1.00), GWPH: 96.11 (+1.79), NUVA: 63.29 (+1.09)
Will Quest Diagnostics' (DGX) Earnings Surprise in Q2?
Zacks Equity Research - Zacks Investment Research - Thu Jul 14, 4:16PM CDT
Quest Diagnostics Inc. (DGX) is scheduled to report its first-quarter 2016 earnings results before the opening bell on Jul 21, 2016.
AMSG: 72.23 (-2.78), HCA: 75.52 (-1.61), DGX: 86.24 (-0.12), COO: 182.61 (+0.14)
Cross Keys Capital Completes Sale of AllegiantMD to Sheridan Healthcare
GlobeNewswire - Tue Jul 12, 10:16AM CDT
Cross Keys Capital, LLC, a leading independent investment banking firm providing M&A advisory services to healthcare companies, is pleased to announce that it has acted as the exclusive financial advisor to AllegiantMD, Inc. and certain affiliated entities in their sale to Sheridan Healthcare, the Physician Services Division of AmSurg Corporation. The transaction was led by Cross Keys' Managing Director Bill Britton and Vice President Marjorie Chang.
AMSG: 72.23 (-2.78)
Quest Diagnostics Estimates Move Up, Tie-Ups to Add Value
Zacks Equity Research - Zacks Investment Research - Tue Jul 12, 7:31AM CDT
On Jul 11, we issued an updated research report on Quest Diagnostics, Inc. (DGX).
AMSG: 72.23 (-2.78), HCA: 75.52 (-1.61), DGX: 86.24 (-0.12), BIOS: 2.58 (+0.02)
ENVISION HEALTHCARE HOLDINGS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to AMSURG Corp.
BusinessWire - Fri Jun 24, 1:17PM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Envision Healthcare Holdings, Inc. ("Envision"
(NYSE: EVHC) concerning the sale to AMSURG Corp. (NASDAQ: AMSG). Under the terms of the agreement, Envision shareholders will only receive 0.334 AMSURG shares for each share owned. The consideration is valued at approximately $26.21, which is significantly lower than the 52-week high and at least one analyst's estimated value of $36.00 per share. AMSG: 72.23 (-2.78), EVHC: 23.59 (-1.00)
INVESTOR ALERT: Levi & Korsinsky, Notifies Envision Healthcare Holdings, Inc. Shareholders of an Investigation Regarding the Fairness of the Sale of the Company to AMSURG Corp. -- EVHC
PR Newswire - Thu Jun 23, 12:09PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
AMSG: 72.23 (-2.78), EVHC: 23.59 (-1.00)
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Envision Healthcare Holdings, Inc. - EVHC
ACCESSWIRE - Wed Jun 22, 8:35PM CDT
BALA CYNWYD, PA / ACCESSWIRE / June 22, 2016 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Envision Healthcare Holdings, Inc. ("Envision" or "the Company"
(NYSE: EVHC) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to AmSurg Corp. ("AmSurg". AMSG: 72.23 (-2.78), EVHC: 23.59 (-1.00)
SHAREHOLDER ALERT: Levi & Korsinsky, Notifies Shareholders of Envision Healthcare Holdings, Inc. of Commencement of an Investigation Regarding the Fairness of the Sale of the Company to AMSURG Corp. -- EVHC
ACCESSWIRE - Tue Jun 21, 5:16PM CDT
NEW YORK, NY / ACCESSWIRE / June 21, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:
AMSG: 72.23 (-2.78), EVHC: 23.59 (-1.00)
ENVISION HEALTHCARE SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Envision Healthcare Holdings, Inc. (EVHC) Over the Proposed Sale of the Company to AmSurg Corp.
PR Newswire - Tue Jun 21, 3:21PM CDT
Nadeem Faruqi, founding partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Envision Healthcare Holdings, Inc. ("Envision Healthcare" or the "Company"
(NYSE:EVHC) for potential breaches of fiduciary duties in connection with the sale of the Company to AmSurg Corp. ("AmSurg" for approximately $4.73 billion. AMSG: 72.23 (-2.78), EVHC: 23.59 (-1.00)
Envision Healthcare Holdings Inc. Acquisition May Not Be in the Best Interests of EVHC Shareholders
PR Newswire - Mon Jun 20, 10:30AM CDT
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Envision Healthcare Holdings Inc. ("EVHC" or the "Company"
in connection with the Company's proposed plan of merger with AmSurg Corp. ("AmSurg", announced on June 15, 2016. Under the terms of the agreement, EVHC shareholders will receive 0.334 of a share of AmSurg common stock for each EVHC share they own, representing consideration of $25.89 per share. AMSG: 72.23 (-2.78), EVHC: 23.59 (-1.00)
Ryan & Maniskas, LLP Announces Investigation of Envision Healthcare Holdings, Inc.
PR Newswire - Fri Jun 17, 9:45AM CDT
Ryan & Maniskas, LLP is investigating potential claims against the board of directors of Envision Healthcare Holdings, Inc. ("Envision" or the "Company"
(NYSE: EVHC) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell the Company to AmSurg Corp. ("AmSurg" in a transaction valued at approximately $4.8 billion. AMSG: 72.23 (-2.78), EVHC: 23.59 (-1.00)
AmSurg, Envision Healthcare Set to Merge by 2016-End
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 8:47AM CDT
Envision shareholders will own 53% of the combined entity while AmSurg (AMSG) shareholders will have 47%.
AMSG: 72.23 (-2.78), EVHC: 23.59 (-1.00), BAX: 48.50 (+0.48), LMAT: 17.89 (+0.69)
Upgrade Alert for Amsurg (AMSG)
Comtex SmarTrend(R) - Fri Jun 17, 3:38AM CDT
Amsurg (NASDAQ:AMSG) was upgraded from Neutral to Buy at BofA/Merrill today. The stock closed yesterday at $78.43 on volume of 3.0 million shares, above average daily volume of 523,000. There is potential upside of 17.0% for shares of Amsurg based on a current price of $78.43 and an average consensus analyst price target of $91.73. The stock should discover initial support at its 200-day moving average (MA) of $76.38 and subsequent support at its 50-day MA of $74.87.
AMSG: 72.23 (-2.78)
Robbins Arroyo LLP: Acquisition of Envision Healthcare Holdings, Inc. (EVHC) by AmSurg Corp. (AMSG) May Not Be in Shareholders' Best Interests
BusinessWire - Thu Jun 16, 1:14PM CDT
Shareholder rights attorneys at Robbins Arroyo LLP are investigating the proposed acquisition of Envision Healthcare Holdings, Inc. (NYSE: EVHC) by AmSurg Corp. (NASDAQ: AMSG). On June 15, 2016, the two companies announced the signing of a definitive merger agreement pursuant to which AmSurg will acquire Envision. Under the terms of the agreement, Envision shareholders will receive 0.334 shares of AmSurg common stock for each share of Envision common stock, the value of which is equivalent to $26.21.
AMSG: 72.23 (-2.78), EVHC: 23.59 (-1.00)
Amsurg Rises 2.23% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Thu Jun 16, 12:37PM CDT
Amsurg (NASDAQ:AMSG) traded in a range yesterday that spanned from a low of $78.00 to a high of $81.13. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $80.02 on volume of 2.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
AMSG: 72.23 (-2.78)
Envision Healthcare and AMSURG Announce Transformational Merger
BusinessWire - Wed Jun 15, 3:30PM CDT
Envision Healthcare Holdings, Inc. (Envision) (NYSE:EVHC) and AMSURG Corp. (AMSURG) (NASDAQ:AMSG) today announced that they have signed a definitive merger agreement pursuant to which the companies will combine in an all-stock transaction at a fixed exchange ratio of 0.334 AMSURG shares per Envision share. The combined organization will have a pro forma market capitalization of approximately $10 billion and enterprise value of approximately $15 billion based on the closing stock prices of Envision and AMSURG on June 14, 2016. Envision shareholders will own approximately 53% percent and AMSURG shareholders will own approximately 47% percent of the combined organization on a fully diluted basis, including preferred shares. The transaction has been unanimously approved by the Boards of Directors of both companies.
AMSG: 72.23 (-2.78), EVHC: 23.59 (-1.00)
Envision Healthcare (EVHC) in Focus: Stock Climbs 8.3% in Session
Zacks Equity Research - Zacks Investment Research - Fri Jun 10, 7:35AM CDT
Envision Healthcare Holdings, Inc. (EVHC) was a big mover last session, as the company saw its shares rise over 8% on the day.
AMSG: 72.23 (-2.78), EVHC: 23.59 (-1.00)
